FIELD: medicine, pharmaceutics.
SUBSTANCE: what is presented is using fumaric acid derivatives specified in a group consisting of dialkylfumarates, monoalkylhydrofumarates, fumaric acid monoalkyl ester salts, fumaric acid monoamides, fumaric acid monoamide salts, fumaric acid diamides, monoalkyl monoamido fumarates, carbocyclic and oxacarbocyclic oligomers of these compounds or their mixtures for preparing a drug for treatment or prevention of cardiac failure, particularly left-ventricular failure, myocardial infarction and angina.
EFFECT: dimethylfumarate has appeared to reduce considerably an area of infarction caused by ischemia followed by reperfusion.
19 cl, 4 dwg, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| USING DERIVATIVES OF FUMARIC ACID IN TREATMENT OF CARDIAC INSUFFICIENCY AND ASTHMA | 2004 |
|
RU2313339C2 |
| DERIVATIVES OF FUMARIC ACID AS NF-kappaB INHIBITOR | 2002 |
|
RU2282440C2 |
| APPLICATION OF FUMARIC ACID DERIVATIVES FOR TREATMENT OF MITOCHONDRIAL DISEASES | 2000 |
|
RU2218918C1 |
| APPLICATION OF ACID ALKYLFUMARATES FOR TREATMENT OF PSORIASIS, PSORIATIC ARTHRITIS, NEURODERMITIS AND CHRONIC CICATRIZING ENTERITIS (CROHN'S DISEASE) | 1998 |
|
RU2197233C2 |
| APPLICATION OF DERIVATIVES OF FUMARIC ACID IN TRANSPLANTATION MEDICINE | 1999 |
|
RU2210364C2 |
| FUMARIC ACID-BASE MICROTABLETS | 1999 |
|
RU2210366C2 |
| APPLICATION OF FUMARIC ACID DERIVATIVES | 1998 |
|
RU2197963C2 |
| DOSAGE FORM IN CAPSULE FORM CONTAINING TABLETS WITH DIMETHYL FUMARATE | 2019 |
|
RU2742745C1 |
| FUMARIC ACID AMIDES | 2002 |
|
RU2290946C2 |
| DIMETHYL FUMARATE-CONTAINING ENTERIC TABLET | 2020 |
|
RU2786364C1 |
